ID
12471
Beschrijving
The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI). https://clinicaltrials.gov/ct2/show/NCT01294462
Link
https://clinicaltrials.gov/ct2/show/NCT01294462
Trefwoorden
Versies (2)
- 28-07-15 28-07-15 -
- 21-11-15 21-11-15 -
Geüploaded op
21 november 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Ticagrelor Versus Clopidogrel Acute Coronary Syndrome NCT01294462
Eligibility criteria
- StudyEvent: ODM
Beschrijving
Exclusion criteria
Beschrijving
Index event is an acute complication of percutaneous coronary intervention
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009566
- UMLS CUI [1,2]
- C1532338
Beschrijving
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
Datatype
boolean
Alias
- UMLS CUI-1
- C1532338
Beschrijving
Oral anticoagulation therapy that cannot be stopped
Datatype
boolean
Alias
- UMLS CUI-1
- C0003281
Beschrijving
The conditions associated with increased risk of bradycardiac events
Datatype
boolean
Alias
- UMLS CUI-1
- C0428977
Similar models
Eligibility criteria
- StudyEvent: ODM
C1532338 (UMLS CUI [1,2])